Ukrainian Journal of Perinatology and Pediatrics. 2024.4(100): 97-105. doi: 10.15574/PP.2024.4(100).97105
Voloshin O. M.^1,2, Marushko Yu. V.¹, Savchenko I. I.², Kashtan I. O.^3
1Bogomolets National Medical University, Kyiv, Ukraine
²Luhansk State Medical University, Rivne, Ukraine
³Rivne regional children’s hospital, Ukraine

For citation: Voloshin OM, Marushko YuV, Savchenko II, Kashtan IO. (2024). Optimization of recurrent respiratory infections prevention in preschool children. Ukrainian Journal of Perinatology and Pediatrics. 4(100): 97-105. doi: 10.15574/PP.2024.4(100).97105.
Article received: Aug 20, 2024. Accepted for publication: Nov 27, 2024.

Recurrent respiratory infections (RRIs) have been, are, and will likely remain a significant challenge in pediatric practice.
Aim – to evaluate the efficacy of the use of bacterial lysate (BL), mineral complex (MC) and symbiotic (SB) for the prevention of RRIs in preschool children.
Materials and methods. The prospective study included 60 children aged 30-42 mos. They had 6 or more episodes of acute respiratory infection (ARI) within the previous year. All the children were divided into a control group (CG, n=30) and an experimental group (EG, n=30). The CG included patients who did not receive any medications to prevent RRI. The EG consisted of children who were prescribed BL, MK and SB according to the original regimen for 3 mos. The results of the study in CG and EG were analyzed at 6 and 12 mos. after the start of the study according to the following criteria: 1) the number of ARI episodes and 2) the total severity score (TSS) of RRIs. Statistical processing of the obtained data was performed using IBM SPSS Statistics 28 software.
Results. The use of BL, MK and SB in preschool children was associated with a marked reduction in the number of ARI episodes during the first 6 mos., as well as a significantly lower the total severity score of RRIs during 12 mos. The calculation of χ² and φ_c coefficients showed an average degree of positive effect of the mentioned prophylactic agents on the accounting clinical indicators. Besides, the odds ratio showed that the use of this prophylactic complex in patients was associated with a 5-fold and 3.6-fold reduction in the probability of their belonging to the subgroup with more frequent ARI episodes after 6 mos. and 12 mos., respectively.
Conclusion. The applied prophylactic complex can be recommended both for children who have previously experienced a recurrent course of ARIs and those with a high susceptibility to such a course, especially in preschool age.
The study was conducted in accordance with the principles of the Declaration of Helsinki.
The study protocol was approved by the Local Ethics Committee of the institution mentioned in the work. An informed parental consent was obtained for the study in children.
No conflict of interests was declared by the authors.
Keywords: preschool children, recurrent respiratory infections, prophylactic remedies.

REFERENCES

1. Alebaji MB, Marie S, Al Kuwaiti N. (2024). Uncovering the Hidden Cause of Recurrent Chest Infections in a Child: A Case Report. International Medical Case Reports Journal. 17: 789-793. https://doi.org/10.2147/IMCRJ.S478959; PMid:39286361 PMCid:PMC11404494

2. Ameli F, Brocchetti F, Mignosi S, Tosca MA, Gallo F, Ciprandi G. (2020). Recurrent respiratory infections in children: a study in clinical practice. Acta Biomedica. 91(4): e2020179. doi: 10.23750/abm.v91i4.8585.

3. Aponte R, Palacios C. (2017). Vitamin D for prevention of respiratory tract infections. URL: https://www.who.int/tools/elena/commentary/vitamind-pneumonia-children.

4. Biezen R, Brijnath B, Grando D, Mazza D. (2017). Management of respiratory tract infections in young children – а qualitative study of primary care providers' perspectives. NPJ Primary Care Respiratory Medicine. 27: 15. https://doi.org/10.1038/s41533-017-0018-x; PMid:28258279 PMCid:PMC5434780

5. Braido F, Melioli G, Nicolini G, Canonica GW. (2023). Prevention of recurrent respiratory tract infections: a literature review of the activity of the bacterial lysate Lantigen B. European review for medical and pharmacological science. 27(16): 7756-7767. URL: https://www.webofscience.com/wos/woscc/full-record/WOS:001076331800039.

6. Cardinale F, Fiore M, Piacentini G, Varricchio A. (2023). OM-85 in the Prevention of Recurrent Respiratory Infections in Children: State of the Art. Journal of Biological Regulators and Homeostatic Agents. 37(11): 5745-5755. https://doi.org/10.23812/j.biol.regul.homeost.agents.20233711.551

7. Castro-Rodriguez JA, Turi KN, Forno E. (2024). A critical analysis of the effect of OM-85 for the prevention of recurrent respiratory tract infections or wheezing/asthma from systematic reviews with meta-analysis. Pediatric Allergy and Immunology. 35(7): e14186. https://doi.org/10.1111/pai.14186; PMid:39016384

8. Chiappini E, Santamaria F, Marseglia GL et al. (2021). Prevention of recurrent respiratory infections. Italian Journal of Pediatrics. 47: 211. https://doi.org/10.1186/s13052-021-01150-0; PMid:34696778 PMCid:PMC8543868

9. Chicoulaa B, Haas H, Viala J, Salvetat M, Olives JP. (2017). How French general practitioners manage and prevent recurrent respiratory tract infections in children: the SOURIRRE survey. International Journal of General Medicine. 10: 61-68. https://doi.org/10.2147/IJGM.S125806; PMid:28293116 PMCid:PMC5345982

10. De Benedictis FM, Bush A. (2018). Recurrent lower respiratory tract infections in children. British Medical Journal. 362: k2698. https://doi.org/10.1136/bmj.k2698; PMid:30002015

11. Eldridge L. (2023). Recurrent Respiratory Infections in Children. Potential Causes and When to See Your Doctor. URL: https://www.verywellhealth.com/recurrent-respiratory-infections-in-children-4778323.

12. Esposito S, Ballarini S, Argentiero A, Ruggiero L, Rossi GA, Principi N. (2022). Microbiota profiles in pre-school children with respiratory infections: Modifications induced by the oral bacterial lysate OM-85. Frontiers in Cellular and Infection Microbiology. 12: 789436. https://doi.org/10.3389/fcimb.2022.789436; PMid:36051241 PMCid:PMC9425436

13. Esposito S, Jones MH, Feleszko W et al. (2020). Prevention of New Respiratory Episodes in Children with Recurrent Respiratory Infections: An Expert Consensus Statement from the World Association of Infectious Diseases and Immunological Disorders (WAidid). Microorganisms. 8(11): 1810. https://doi.org/10.3390/microorganisms8111810; PMid:33213053 PMCid:PMC7698530

14. Khan Laghari I, Nawaz T, Mustafa S, Jamali AA, Fatima S. (2023). Role of multi-strain probiotics in preventing severity and frequency of recurrent respiratory tract infections in children. BMC Pediatrscs. 23(1): 505. https://doi.org/10.1186/s12887-023-04338-x; PMid:37817096 PMCid:PMC10566059

15. Marseglia GL, Gelardi M, Santus P, Ciprandi G. (2024). Reappraisal of Pidotimod: an immunomodulatory agent with 30-year evidence. Minerva Medica. 115(4): 503-515. https://doi.org/10.23736/S0026-4806.24.09391-1; PMid:39016527

16. Nagaraju K, Shah R, Ganapathy S et al. (2021). Practical Approach for the Diagnosis, Prevention, and Management of Recurrent Upper Respiratory Tract Infection in Children: Report from an Expert Closed-group Discussion. Pediatric Infectious Disease. 3: 105-112. https://doi.org/10.5005/jp-journals-10081-1321

17. Ostrzyżek-Przeździecka K, Panczyk M, Bronikowski M, Gasior JS, Feleszko W. (2023). Association of low physical activity with higher respiratory tract infections frequency among pre-school children. Pediatric Research. 94(2): 594-602. https://doi.org/10.1038/s41390-022-02436-7; PMid:36690745

18. Pasternak G, Lewandowicz-Uszyńska A, Królak-Olejnik B. (2020). Recurrent respiratory tract infections in children. Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego. 49(286): 260-266. PMID: 32827422.

19. Romanko MR. (2021). Recurrent episodes of viral croup in children: potential causes and approaches to its prevention. Modern pediatrics. Ukraine. 3: 15-22. https://doi.org/10.15574/SP.2021.115.15

20. Synoverska OB, Berezna TH, Vovk ZV, Lazurkevych KhO, Yakubiv-Han IH. (2020). Recurrent respiratory diseases in children: new opportunities for prevention. Child's Health. 15(4): 21-26. URL: http://www.mif-ua.com/archive/article/49524.

21. Voloshin OM. (2023). A comprehensive assessment of postnatal risk factors associated with recurrent respiratory infections in preschool children. Ukrainian Journal Perinatology and Pediatrics. 4: 81-90. https://doi.org/10.15574/PP.2023.96.81

22. Zhang X, Dai X, Li X et al. (2024). Recurrent respiratory tract infections in children might be associated with vitamin A status: a case-control study. Frontiers in Pediatrics. 11: 1165037. https://doi.org/10.3389/fped.2023.1165037; PMid:38250588 PMCid:PMC10796697

23. Zuccotti GV, Mameli C. (2015). Respiratory infections and immunostimulants in childhood: an update. Journal of Pediatric and Neonatal Individualized Medicine. 4(2): e040218. doi: 10.7363/040218.